Vibrio cholerae causes a dehydrating diarrheal illness that can be rapidly fatal in the absence of specific treatment. The organism is an historic scourge and, like similar infectious diseases, may have influenced the evolution of the human genome. We report here the results of the first candidate gene association study of cholera. In a family-based study of 76 pedigrees from Dhaka, Bangladesh, we evaluated the association between cholera and five candidate genes-the cystic fibrosis transmembrane receptor; lactoferrin; long palate, lung and nasal epithelium clone 1 (LPLUNC1); estrogen-related receptor alpha and calcium-activated chloride channel 1. We found a significant association with a marker in the promoter region of LPLUNC1 (rs11906665), a member of a family of evolutionarily conserved innate immunity proteins. An earlier microarray-based study of duodenal biopsies showed significantly increased expression of LPLUNC1 in cholera patients compared with healthy control subjects. Our results suggest that variation in host innate immune responses may influence the outcome of exposure to V. cholerae in an endemic setting.
Introduction
Vibrio cholerae may have played an influential role in shaping the human genome. Historical documents describe a dehydrating diarrheal disease consistent with cholera as long ago as the seventh century, and seven pandemics with high rates of associated mortality have swept the globe in the last three centuries. Individuals with blood group O are at increased risk of severe cholera, 1 and it has been hypothesized that V. cholerae infection may have selected for the low prevalence of the O blood group in the Ganges Delta region, a historical and current epicenter of cholera. 2 In a family-based study of cholera in Bangladesh, we have recently shown that individuals who are firstdegree relatives of an index patient with cholera have significantly greater odds of being infected with V. cholerae compared with unrelated or less closely related contacts, when living in the same household. This finding was independent of blood group phenotype in a multivariate analysis. 3 To begin to evaluate host genetic factors influencing susceptibility to cholera, we performed a family-based candidate gene association study in a cohort of individuals living in a cholera-endemic area of Bangladesh. We selected five candidate genes based on biologically plausible associations with V. cholerae infection. First, we included the cystic fibrosis transmembrane receptor, as cholera has been speculated to be the selective pressure for the cystic fibrosis trait. 4, 5 A recently-completed microarraybased study of duodenal biopsies of cholera patients from Bangladesh showed increased expression of a number of innate immune effectors, compared with healthy control subjects. 6 We therefore included the two most highly upregulated genes identified in this study, lactoferrin (LTF) and long palate, lung and nasal epithelium clone 1 (LPLUNC1), as well as a nuclear steroid receptor that regulates lactoferrin production, estrogen related receptor alpha (ESRRA). Finally, we included calcium activated chloride channel 1 (CLCA), which was detected in high levels in a proteomic evaluation of human cholera stools (unpublished data).
Results

Characteristics of the study population
The study population is comprised of index cases with cholera and their family members, all of whom share household and cooking facilities. The index cases presented to the Dhaka hospital of the International Centre for Diarrhoeal Disease Research in Bangladesh (ICDDR,B) between January 2004 and November 2005. A diagnosis of cholera in an index case was made by the presence of acute watery diarrhea and a stool culture positive for V. cholerae. Family members of the index case were defined as affected with cholera if they had a positive rectal swab culture for V. cholerae or symptoms of diarrhea during 21 days of follow-up. For this analysis, the index cases and affected relatives were classified as affected, and all others were classified as unaffected.
Two hundred and seventy-seven individuals in 76 pedigrees were included in the study. In two-thirds of the pedigrees, the index case was a child. Seventy-three pedigrees were nuclear families; three pedigrees additionally contained grandparents or grandchildren. Table 1 shows the structure of the families included in the association study, categorized by the number of affected children per family. Table 2 shows the clinical features of the index cases as well as of the affected and unaffected relatives. The mean ages differed between unaffected relatives (26 ± 15 years), affected relatives (20±14.5 years) and index cases (18.7 ± 14.5 years). The higher age among unaffected relatives likely reflects immunity acquired with age among individuals living in an endemic setting. Consistent with pre-existing immunity, there was a trend toward higher vibriocidal titers (representing antibodies directed at the whole organism) in unaffected individuals. As expected, the index cases and affected relatives were non-significantly enriched for blood group O, an earlier identified risk factor for severe cholera.
Family-based association analysis of SNPs in five candidate genes with cholera We evaluated single nucleotide polymorphisms (SNPs) in five candidate genes-CLCA, CFTR, ESRRA, LTF and LPLUNC1-for an association with cholera in the 76 pedigrees. As outlined in Table 3 , a total of 145 SNPs in the five genes passed quality control and were included in the analysis.
We performed the transmission disequilibrium test (TDT) on SNPs in each of the five candidate genes, using Haploview version 4.1. Supplementary Table 1 contains the results of the TDT for all SNPs. Table 4 shows the SNPs that were associated with cholera with a nominal P-value o0.05. One variant in a coding region of ESRRA, two variants in different regions of the CFTR gene and nine variants in LPLUNC1, primarily in the promoter region, were associated with cholera. Following permutation testing, only rs11906665, a variant in the promoter region of LPLUNC1, remained significantly associated with cholera. In particular, transmission of the A allele was associated with cholera.
The FBAT statistical package extends the methodology of the TDT to evaluate nuclear families that include both affected and unaffected offspring, and it also allows for missing parental data. Due to the varying affection status and family structure of these pedigrees, we performed focused association testing of the SNPs outlined in Table 4 using FBAT. Bi-allelic testing was performed with an additive model. The FBAT results, shown in Table 5 , confirm the findings from the TDT. The most highly associated SNP by FBAT was rs11906665 in LPLUNC1 (P ¼ 0.0019).
Haplotype-specific association analysis
We performed a haplotype-based association analysis for SNPs in the candidate genes. Linkage disequilibrium between SNPs was inspected using Haploview, with haplotypes defined by solid spine of linkage disequilibrium (D 0 40.9). Common haplotypes with frequencies 45% were observed in blocks for each candidate gene. After permutation testing was applied, no haplotype blocks, as defined by a D 0 40.9, were significantly Only the nuclear families from three multigenerational pedigrees were included. Continuous variables were compared using one-way ANOVA and dichotomous variables were compared using two-sided Pearson's w 2 test. c associated with cholera for any of the candidate genes (data not presented).
As we observed the strongest association with a variant in LPLUNC1 (rs11906665), we additionally evaluated a 3 kb block comprised of rs17124508, rs11906665, rs1884884, rs17307318 and rs8115852, defined by a D 0 of 1.0. Figure 1 shows this block, which is located in the 5 0 -promoter region of LPLUNC1. Table 6 shows the haplotype frequencies and the results of the TDT for this block. Two haplotypes that differed only by the alleles of rs11906665 were significantly associated with cholera after permutation testing (P ¼ 0.001 and P ¼ 0.012).
Discussion
Substantial observational evidence has suggested that human genetic factors may influence susceptibility to V. cholerae infection. To date, no specific genetic association studies have been performed in cholera patients, although individuals with blood group O have been observed to be at higher risk of severe disease than those of other blood groups. 1 In this study, we used a familybased cohort in an endemic area to investigate the association between cholera and SNPs in five candidate genes. We found a variant in the promoter region of LPLUNC1 to be significantly associated with cholera. This association was robust and was identified using two family-based tests, the TDT and FBAT.
LPLUNC1 is a member of a family of evolutionarily conserved innate immunity proteins that have been best studied in the palate, lung and nasal epithelium. The short palate, lung and nasal epithelium clone 1 protein (SPLUNC1), a close relative of LPLUNC1, has been shown to inhibit growth of Pseudomonas aeruginosa in vitro and to bind to lipopolysaccharide of the organism. 7 A recent whole-genome microarray screen of gene expression in the duodenal mucosa of patients with cholera showed LPLUNC1 to be greater than sevenfold more highly expressed during the acute phase of infection than during the convalescent phase; 6 these findings were further confirmed by reverse transcriptase-PCR. This microarray study showed a novel association between LPLUNC1 and cholera, and generated the biological underpinnings to support the study of LPLUNC1 as a candidate gene for susceptibility to cholera.
The study of the role of host genetics in susceptibility to enteric infections is in its infancy. Immune response genes, particularly those in the human leukocyte antigen locus, have been the most frequently identified host susceptibility factors. 8 In a study of North American travelers to Mexico, a variant in exon 15 of lactoferrin was found to be associated with travelers' diarrhea. 9 Similar to LPLUNC1, lactoferrin is a component of the innate immune system that has antimicrobial and immunoregulatory properties. Taken together with these results, this finding indicates that further studies of the relationship between variants in host innate immunity genes and the outcome of exposure to enteric organisms may be productive.
The variant in LPLUNC1 that we identified as associated with cholera, rs11906665, may not be the causal variant. Our haplotype analysis showed a haplotype containing rs11906665 to be more significantly associated with cholera than the variant itself. The variant is located in the promoter region of the gene, Our study has strengths and limitations. The study population was comprised of nuclear families sharing water, cooking and hygiene facilities; thus, all individuals within the household were likely to have been 
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RC LaRocque et al exposed to V. cholerae along with the index case. By prospectively following family members for 3 weeks following the presentation of the case, we were able to obtain accurate phenotype information on these individuals for the current exposure. Nevertheless, individuals who were classified as unaffected for this analysis may have been infected with V. cholerae in the past; such misclassification may have limited the power of our analysis. Although we were able to detect evidence of an association between cholera and LPLUNC1, we cannot exclude additional effects of the four other genes evaluated. Validation of the association with LPLUNC1 should be carried out in other populations with exposure to V. cholerae, and further biological data delineating the mechanism of the observed association between LPLUNC1 and cholera are needed. As it is likely that more than one host genetic factor might contribute to susceptibility to cholera, a genome-wide search for additional associated loci is planned, with the aim of identifying other chromosomal regions related to this important global disease.
Materials and methods
Study subjects
Samples were collected as part of a household-based prospective observational study aimed at identifying immunological and host factors associated with the risk of cholera in an endemic setting. The study design has been described earlier. 3, 10 Briefly, index cases presenting to the ICDDR,B hospital with severe acute watery diarrhea were eligible for inclusion if their stool cultures were subsequently positive for V. cholerae, if they were older than 6 months, and if they were without significant comorbid conditions. All index cases included in this analysis were infected with V. cholerae O1 El Tor. On presentation of the index case, a field team discussed enrollment with family members sharing a household with the index case, and consenting individuals were enrolled into the study immediately on culture confirmation of the index case. Enrollment of family members typically occurred within 24 h of presentation of the index case. All enrolled family members shared the same household and cooking pot as the index cases for at least the three preceding days. Blood specimens were collected from index cases and consenting relatives on enrollment and over the course of follow-up. The field team visited households on each of the next 6 days, and again on days 14 and 21. During these visits, relatives were questioned about diarrheal symptoms, and rectal swabs were obtained for V. cholerae culture. Diarrhea was defined as three or more loose stools within a 24 h period. Among relatives in this study, cholera was defined as a positive rectal swab culture for V. cholerae or symptoms of diarrhea during the 21 days of follow-up.
Informed consent for participation in this research was obtained from participants or their guardians. The human experimentation guidelines of the US Department of Health and Human Services were followed in the conduct of this research. Approval for this human study was obtained from the Institutional Review Board of the Massachusetts General Hospital and the Research and the Ethical Review Committees of the ICDDR,B.
DNA extraction
Peripheral blood mononuclear cells were isolated from venous blood by gradient centrifugation on FicollIsopaque (Pharmacia, Uppsala, Sweden). Cells were transferred to a cell lysis solution, and DNA was extracted according to the manufacturer's protocol, including treatment with RNAse A (Gentra Puregene, Qiagen, Valencia, CA, USA). DNA concentration was determined by spectrophotometry.
Genotyping
Five genes were selected for inclusion in the candidate gene association study. SNPs located within these genes or within 10 kb in either direction from the gene were selected using data from dbSNP (http://www.ncbi.nlm. nih.gov/projects/SNP/). Selection focused on the inclusion of validated, coding and tagging SNPs (Tagger).
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Genotyping for selected SNPs was performed using the iPlex Gold genotyping system (Sequonom, Newton, MA, USA). Primers for each evaluated SNP were designed using PrimerExpress (Applied Biosystems, Foster City, CA, USA) and checked using Sequonom Real SNP Assay Design software (Sequonom, Newton, MA, USA). Genotyping was performed on the study subjects as well as on a panel of individuals from the Caucasian population of the International HapMap Project for validation. Only SNPs with genotyping percentages X90% in the Caucasian and study populations, as well as minor allele frequencies X0.01 and Hardy-Weinberg P-values X0.01 in the study population, were included in the analysis. Any marker genotype inconsistencies were evaluated and the genotypes were zeroed for those select pedigrees.
Statistical analyses
Quality assessment of the genotyping results was performed using Haploview version 4.1. 12 The TDT Results of 100 000 cycles of permutation testing performed in Haploview version 4.1.
LPLUNC1 and cholera RC LaRocque et al was performed with Haploview version 4.1. Familialbased association testing was performed using the FBAT statistical package version 2.0.2c (http://www.biostat.harvard.edu/~fbat/default.html). Haplotypes were estimated using an E-M algorithm in Haploview version 4.1; haplotype blocks were defined using a solid spine of linkage disequilibrium (D 0 40.9) unless otherwise indicated. Permutation testing was done within Haploview using 100 000 permutations for single markers and haplotypes; both nominal and empirical Pvalues are reported. Descriptive statistics were performed using SPSS version 10.1. Continuous variables were compared using one-way ANOVA and dichotomous variables were compared using two-sided Pearson's w 2 test.
